Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

CNS-Neurology Companies in BioPortfolio's Corporate Database - Page: 2Twitter RSS

17:00 EDT 20th April 2014 | BioPortfolio

CNS-Neurology company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest CNS-Neurology companies that have been added to our BioPortfolio's life-science corporate directory.

Search For More CNS-Neurology Companies

If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More CNS-Neurology Companies.

More Information about CNS-Neurology on BioPortfolio

We have published hundreds of CNS-Neurology news stories on BioPortfolio along with dozens of CNS-Neurology Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about CNS-Neurology for you to read.

Showing "neurology nervous" Companies 26 to 50 of 325

Monday 3rd June 2013

Bioness Inc.

Bioness offers innovative Neuromodulation products designed to help certain individuals with central nervous system disorders and diseases such as Stroke, Multiple Sclerosis, Traumatic Brain Injury, Cerebral Palsy and Spinal Cord Injury. These products use electrical stimulation to help people regain mobility, physical independence and productivity.

Friday 31st May 2013


SYGNIS Pharma AG, headquartered in Heidelberg, is a specialty pharmaceutical company listed on the Prime Standard of the German stock exchange. The Company is focused on the research, development and marketing of innovative therapies for the treatment of disorders of the Central Nervous System. These include stroke, amyotrophic lateral sclerosis (ALS) and neurological disorders resulting from in...

Wednesday 29th May 2013

Euthymics Bioscience, Inc.

DOV is a biopharmaceutical company historically focused on the development of novel product candidates for disorders of the central nervous system. DOV has previously funded drug development and discovery programs that are now at the preclinical, Phase I and Phase II clinical stages focused on monoamine reuptake inhibitors.

Thursday 23rd May 2013

John Muir Health

John Muir Health is a not-for-profit organization that includes two of the largest medical centers in Contra Costa County: John Muir Medical Center - Walnut Creek Campus, a 330-bed acute care medical center that serves as Contra Costa County's only designated trauma center; and John Muir Medical Center - Concord Campus, a 254-bed acute care medical center...

Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalat...

Wednesday 22nd May 2013

Merz North America

Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in aesthetics, dermatology and neurology in the U.S. and Canada. Our ambition is to become a recognized leader in the treatment of movement disorders, and in aesthetics and dermatology. Our future is promising, and we are committed to advanc...

Tuesday 21st May 2013

Acorda Therapeutics

Acorda Therapeutics, Inc. was established in March 1995 to develop therapeutic products for spinal cord injury ("SCI") and other central nervous system disorders. Acorda is focusing its initial development efforts on a range of therapeutics for individuals with chronic, or long term, SCI. Currently, there is no therapy that improves neurological function in chronic SCI patients.However, Acorda's c...

KineMed, Inc.

KineMed, Inc. ("KineMed" or the "Company") is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag™ and KineMarker™) to both identify active drug candidates preclinically and confirm their therapeutic activity and dose response in first-in-man studies. The Company is working to develop drug...

Monday 20th May 2013

Itamar Medical Ltd.

Itamar Medical Ltd. is a publicly-traded medical technology company utilizing PAT™ (Peripheral Arterial Tone) signal technology and applications. The PAT signal is a non-invasive "window" to both the cardiovascular and autonomic nervous systems. For more information, visit

Thursday 16th May 2013

Sunovion Pharmaceuticals Inc.

Sunovion is a leading pharmaceutical company dedicated to discovering, developing and commercializing therapeutic products that advance the science of medicine in the central nervous system (CNS) and respiratory disease areas and improve the lives of patients and their families. Sunovion’s drug development program, together with its corporate developm...

Thursday 9th May 2013

Vitera Healthcare Solutions

Vitera Healthcare Solutions, formerly Sage Healthcare, provides end-to-end clinical and financial technology solutions to more than 400,000 healthcare professionals including 80,000 physicians. Vitera Healthcare Solutions provides electronic health records and practice management systems, processes 33 million transactions and 1.8 million e-prescriptions mo...

Forest Laboratories, Inc.

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people’s lives. In addition to its well-established franchises in therapeutic areas of the central nervous and cardiovascular systems, Forest’s current pipeline...

Wednesday 8th May 2013

Teva Pharmaceuticals USA, Inc.

Alexza Pharmaceuticals is focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions, including agitation, acute repetitive seizures and insomnia. Alexza's products are based on the Staccato® system, a hand-held inhaler that is designed to deliver a drug aerosol...

Saturday 4th May 2013


The Meiji Seika group, through its life science businesses, which offers “good taste and health,” is working to increase the global respect its products enjoy. We plan to achieve this goal by making the most of the strong Meiji brand, as well as the technologies we have developed over our many years of success. The group operates with the synergy of skill and know-how from its three ma...

Molecular Insight Pharmaceuticals

Molecular Insight Pharmaceuticals, Inc. is focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose, treat and manage disease. The company's two lead compounds, Zemivaâ„¢ and Azedraâ„¢, are in advancing clinical programs. Molecular Insight has completed a Phase 2b clinical trial for its lead cardio...


Neotonus, Inc. is the inventor of Extracorporeal Magnetic Innervation (ExMIâ„¢) technology which combines a basic principle of magnetics with the body's own physiology to provide non-invasive and painless treatments for a growing number of neuromuscular disorders. Neotonus originally developed ExMI in collaboration with physicians at Emory University School of Medicine and engineers at Georgia...

Ipsen S.A.

Ipsen is a global biopharmaceutical group, with sales exceeding 1 billion euros in 2009. The Group has total worldwide staff of more than 4,400 employees, of which nearly 900 contribute to the discovery and development of innovative drugs for patient care. Ipsen’s development strategy is based on fast growing specialty care drugs in oncology, endocrin...

Teikoku Pharma USA, Inc.

Teikoku Pharma USA, Inc., a wholly-owned subsidiary of Teikoku Seiyaku Co., Ltd. that is a leading supplier of the topical analgesic transdermal patch, Lidoderm®, in the world, is a specialty pharmaceutical company that develops and manufactures enhanced pharmaceutical products with its transdermal drug delivery technology. Teikoku focuses its efforts o...

NeurAxon Inc.

NeurAxon, Inc. ( discovers and develops next-generation pain therapeutics focused on its first-in-class selective inhibitors of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.

Snowdon, Inc.

Snowdon, Inc., is a biopharmaceutical company that specializes in the discovery and development of novel small-molecule therapeutics for the treatment of pain, infectious diseases and nervous system disorders. By applying its proprietary E-Prospector platform technology together with its expertise in medicinal chemistry, pharmacology, and computational dru...

Itamar-Medical Inc.

Itamar Medical Ltd. is a publicly-traded medical technology company (TASE: ITMR) utilizing PAT™ (Peripheral Arterial Tone) signal technology and applications. The PAT signal is a non-invasive "window" to both the cardiovascular and autonomic nervous systems.

AB Science SA

Founded in 2001, AB Science is a pharmaceutical company specialising in the research, development and commercialisation of protein kinase inhibitors (PKIs), a new class of targeted molecules whose action is to modify signalling pathways within cells. Through these PKIs, the Company targets diseases with high unmet medical needs (cancer, inflammatory diseas...

PhysioSonics, Inc.

PhysioSonics is a medical device company that has developed a non-invasive system for neuro-monitoring with proprietary technology and IP. Its product line provides improved management for traumatic brain injury, brain hemorrhage and interoperative monitoring in both cardiology and neurology. Its founders include Robert Frederickson Ph.D., Michel Kliot M.D...

Forest Laboratories, Inc. and Clinical Data, Inc.

Forest Laboratories’ (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well-established central nervous system and cardiovascular franchises and innovations in anti-infective medicine. The Company’s pipeline, the most robust in its history, includes...

Gulf Coast Veterinary Neurology & Neurosurgery

Gulf Cost Veterinary Neurology & Neurosurgery is a specialty referral practice committed to the care and treatment of companion animals with medical and surgical neurological conditions. The Houston center features some of the most sophisticated diagnostic imaging equipment and the largest, most experienced team of board-certified veterinary neurologists a...

More From BioPortfolio on "CNS-Neurology Companies in BioPortfolio's Corporate Database - Page: 2"

Search BioPortfolio:

Corporate Database Quicklinks